Announcements Trials

Browse Landscape

Phase

Status

Unknown 5 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Advanced Cancer 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Stereotactic Body Radiation Therapy 1 Sarcoma 1 Recurrence 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Pheochromocytoma 1 Paraganglioma, Extra-Adrenal 1 Paraganglioma 1 Pancreatic Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colonic Neoplasms 1 Carcinoma, Medullary 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advanced Malignancy 1 Advanced Endometrial Cancer 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 117 Oxaliplatin 111 Fluorouracil 100 Capecitabine 90 Docetaxel 69 Leucovorin 60 Irinotecan 57 Paclitaxel 49 S 1 (combination) 38 pembrolizumab 35 Trastuzumab 31 Radiotherapy 25 Bevacizumab 20 Nivolumab 19 Epirubicin 19 titanium silicide 18 Surgical Procedures, Operative 17 Carboplatin 17 Ramucirumab 16 Cetuximab 15 Gastrectomy 13 apatinib 12 Everolimus 12 Gemcitabine 11 Albumin-Bound Paclitaxel 10 Neoadjuvant Therapy 8 Folfox protocol 8 Drug Therapy 8 Chemotherapy, Adjuvant 8 Radiation 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × anlotinib × Clear all

NCT04963088 2025-06-26

TALENT

The First Affiliated Hospital with Nanjing Medical University

Phase 1/2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡